These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31943655)

  • 1. Sarcopenia increases 1-year mortality after surgical resection of hepatocellular carcinoma.
    Salman MA; Omar HSE; Mikhail HMS; Tourky M; El-Ghobary M; Elkassar H; Omar MG; Matter M; Elbasiouny AM; Farag AM; Shaaban HE; Atallah M; Elshabacy O; Salman AA
    ANZ J Surg; 2020 May; 90(5):781-785. PubMed ID: 31943655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
    Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
    Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
    Omiya S; Komatsu S; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Sofue K; Yano Y; Sakai Y; Yanagimoto H; Toyama H; Ajiki T; Fukumoto T
    Anticancer Res; 2021 Nov; 41(11):5775-5783. PubMed ID: 34732451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection.
    Yanagaki M; Haruki K; Taniai T; Igarashi Y; Yasuda J; Furukawa K; Onda S; Shirai Y; Tsunematsu M; Ikegami T
    J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):453-461. PubMed ID: 36181339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma free amino acids are associated with sarcopenia in the course of hepatocellular carcinoma recurrence.
    Sano A; Tsuge S; Kakazu E; Iwata T; Ninomiya M; Tsuruoka M; Inoue J; Masamune A
    Nutrition; 2021 Apr; 84():111007. PubMed ID: 33745507
    [TBL] [Abstract][Full Text] [Related]  

  • 11.  Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
    Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.
    Voron T; Tselikas L; Pietrasz D; Pigneur F; Laurent A; Compagnon P; Salloum C; Luciani A; Azoulay D
    Ann Surg; 2015 Jun; 261(6):1173-83. PubMed ID: 24950264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis.
    Kim TH; Jung YK; Yim HJ; Baik JW; Yim SY; Lee YS; Seo YS; Kim JH; Yeon JE; Byun KS
    Clin Mol Hepatol; 2022 Oct; 28(4):876-889. PubMed ID: 36117443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
    J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma.
    Yang J; Chen K; Zheng C; Chen K; Lin J; Meng Q; Chen Z; Deng L; Yu H; Deng T; Bo Z; He Q; Wang Y; Chen G
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2383-2392. PubMed ID: 35854105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection.
    Dello SA; Lodewick TM; van Dam RM; Reisinger KW; van den Broek MA; von Meyenfeldt MF; Bemelmans MH; Olde Damink SW; Dejong CH
    HPB (Oxford); 2013 Mar; 15(3):165-9. PubMed ID: 23020663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.
    Harimoto N; Shirabe K; Yamashita YI; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y; Nishie A; Yamanaka T
    Br J Surg; 2013 Oct; 100(11):1523-30. PubMed ID: 24037576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma.
    Levolger S; van Vledder MG; Muslem R; Koek M; Niessen WJ; de Man RA; de Bruin RW; Ijzermans JN
    J Surg Oncol; 2015 Aug; 112(2):208-13. PubMed ID: 26266324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma.
    Yang JF; Huang WY; Lo CH; Lee MS; Lin CS; Shen PC; Dai YH; Wang YF; Chen TW
    Sci Rep; 2022 Nov; 12(1):19100. PubMed ID: 36352042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.